Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

Published:2013-12 Issue:6 Volume:24 Page:777-790
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Chapuy Bjoern,McKeown Michael R.,Lin Charles Y.,Monti Stefano,Roemer Margaretha G.M.,Qi Jun,Rahl Peter B.,Sun Heather H.,Yeda Kelly T.,Doench John G.,Reichert Elaine,Kung Andrew L.,Rodig Scott J.,Young Richard A.,Shipp Margaret A.,Bradner James E.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference52 articles.

1. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein;Bartholomeeusen;J. Biol. Chem.,2012

2. Roles of BCL6 in normal and transformed germinal center B cells;Basso;Immunol. Rev.,2012

3. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription;Bisgrove;Proc. Natl. Acad. Sci. USA,2007

4. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma;Caro;Cancer Cell,2012

5. SYK inhibition modulates distinct PI3K/AKT-dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas;Chen;Cancer Cell,2013

Cited by 643 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current status and future trends of BET research in oncology;Heliyon;2024-09

2. Construction of a 5-Gene super-enhancer-related signature for osteosarcoma prognosis and the regulatory role of TNFRSF11B in osteosarcoma;Translational Oncology;2024-09

3. Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC;Cell Communication and Signaling;2024-08-27

4. Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC;Journal of Thoracic Oncology;2024-08

5. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies;Cancer Cell;2024-08